Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040554 | SCV000064245 | likely benign | not specified | 2016-05-18 | criteria provided, single submitter | clinical testing | p.Thr20867Thr in exon 275 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue. It has been ident ified in 1/66632 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs397517684). |
Gene |
RCV000714085 | SCV000531489 | likely benign | not provided | 2018-04-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24503780) |
Athena Diagnostics | RCV000714085 | SCV000844752 | benign | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001471434 | SCV001675538 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-07-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839685 | SCV002100297 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839686 | SCV002100298 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839687 | SCV002100299 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839684 | SCV002100300 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326751 | SCV002627635 | likely benign | Cardiovascular phenotype | 2022-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486594 | SCV004240088 | likely benign | Cardiomyopathy | 2023-06-06 | criteria provided, single submitter | clinical testing |